Skip to main navigation Skip to search Skip to main content

Protocol EFG 10002 A Double Blind, Placebo Controlled Parallel Study to Investigate the Safety, Tolerability and Pharmacokinetics of Multiple Oral GW572016 Doses in Healthy Subjects

Grants and Contracts Details

StatusFinished
Effective start/end date6/1/01 → 5/31/02

Funding

  • Glaxo Wellcome: $700,125.00